Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-Human ANGPTL8 Antibody (SAA1698)

Catalog #:   RHJ09801 Specific References (20) DATASHEET
Host species: Mouse
Isotype: IgG2a, kappa
Applications: ELISA
Accession: Q6UXH0
Overview

Catalog No.

RHJ09801

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a, kappa

Clonality

Monoclonal

Target

Lipasin, C19orf80, ANGPTL8, RIFL, Refeeding-induced fat and liver protein, Angiopoietin-like protein 8, Betatrophin

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q6UXH0

Applications

ELISA

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA1698

Data Image
References

Angiopoietin-like protein inhibitors: Promising agents for the treatment of familial hypercholesterolemia and atherogenic dyslipidemia., PMID:40344904

Inhibition of the ANGPTL3/8 Complex for the Prevention and Treatment of Atherosclerotic Cardiovascular Disease., PMID:39565562

Angiopoietin-Like Proteins: Cardiovascular Biology and Therapeutic Targeting for the Prevention of Cardiovascular Diseases., PMID:37295611

An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif., PMID:35307397

The Potential of ANGPTL8 Antagonism to Simultaneously Reduce Triglyceride and Increase HDL-Cholesterol Plasma Levels., PMID:34869703

Angiopoietin-like proteins 3, 4 and 8 are linked to cardiovascular function in naïve sub-clinical and overt hypothyroid patients receiving levothyroxine therapy., PMID:34739390

ANGPTL3 as therapeutic target., PMID:34581310

Angiopoietin-like proteins in atherosclerosis., PMID:34153276

The Angiopoietin-Like Protein 3 and 8 Complex Interacts with Lipoprotein Lipase and Induces LPL Cleavage., PMID:33656326

Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders., PMID:31856617

Decreased circulating levels of ANGPTL8 in Graves' disease patients., PMID:30900216

New insights into angiopoietin-like proteins in lipid metabolism and cardiovascular disease risk., PMID:30893111

Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia., PMID:29752428

Increased thermogenesis by a noncanonical pathway in ANGPTL3/8-deficient mice., PMID:29358393

Angiopoietin-like 3 in lipoprotein metabolism., PMID:28984319

A New Tactic for Label-Free Recognition of β-Trophin via Electrochemiluminescent Signalling on an AuNPs Supported Immuno-Interface., PMID:28894260

ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearance., PMID:28413163

ANGPTL8 Blockade With a Monoclonal Antibody Promotes Triglyceride Clearance, Energy Expenditure, and Weight Loss in Mice., PMID:28204173

Circulating Betatrophin Is Increased in Patients with Overt and Subclinical Hypothyroidism., PMID:27213151

A lipasin/Angptl8 monoclonal antibody lowers mouse serum triglycerides involving increased postprandial activity of the cardiac lipoprotein lipase., PMID:26687026

Datasheet
$ 328
Product specifications
100 μg 328 1 mg 1640

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human ANGPTL8 Antibody (SAA1698) [RHJ09801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only